Innlanz Limited (ASX: INL) (formerly Mediland Pharm Limited) is a Sydney-based company listed on the Australian Securities Exchange. The Company began its journey over 19 years ago focusing on providing the best of Australian and New Zealand health and well-being products to the discerning customer, both local and international visitor alike, at exceptional value. By 2020, the Company was servicing the needs of thousands of visitors annually from China via its five retail outlets in Sydney, Melbourne, the Gold Coast and New Zealand.
Then the Covid-19 pandemic hit, and international and local travel all but ceased. As with any adversity, opportunities arise, and, just like many organisations across the globe, Innlanz diversified its operations into the hospitality sector by acquiring its first hotel, Heartland the Ambassador Hotel Hamilton in New Zealand, which had maintained strong occupancy rates thanks to New Zealand’s ability to maintain an open and mainly Covid-free lifestyle.
Innlanz’s much vaunted health and wellbeing retail operations are currently suspended, pending the opening up of local and international borders. In the meantime, we are not standing still. We are currently focused on further expanding our hotel portfolio and sourcing opportunities both in Australia and New Zealand.
Innlanz Limited began operations in 2002, by establishing its first retail outlet in Sydney selling health and well-being supplements to international tourists. Soon after, the operations were expanded with additional retail stores opening in both Melbourne and Gold Coast.
On 22 Feb 2019, Innlanz Limited reached another milestone by commencement of trading on the Australian Securities Exchange with the focus on growing so that it can provide returns to its investors.
Always seeking opportunities to expand, with the impact of Covid 19, the Company further diversified its operations by entering into the hospitality sector when it acquired its first hotel in April 2021.
Innlanz Limited is proudly owned and operated within Australia and New Zealand. Our experienced Board and Management team strive to continually meet or exceed the expectations of our consumers, our partners and our investors.
Our VisionTo meet or exceed our customers’ and investor’s expectations.
To continue pursuing opportunities to expand and diversify our revenue streams.
To grow and strengthen the Company in order to thrive in these unprecedented times.
Dr Peter French
Biotechnologist, Doctor of Philosophy (PhD), Master of Business Administration (MBA)
Dip. Human Resources, Workplace Health and Safety, Training and Education
Masters Degree in Finance and Accounting
Certified in Asset Management and Hotel Real Estate Investments
Bachelor of Accounting, Masters of Applied Finance,
Chief Financial Officer:
Bachelor of Commerce, CPA
Bachelor of Arts Degree in Accounting and Financial Management, CA, MAICD.